Revvity (NYSE:RVTY) Shares Unloaded by Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Revvity Inc. (NYSE:RVTY). In a filing disclosed on October 12th, the Representative disclosed that they had sold between $15,001 and $50,000 in Revvity stock on September 9th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Benchmark Electronics (NYSE:BHE) on 10/1/2026.
• Sold $1,001 – $15,000 in shares of Oxford Industries (NYSE:OXM) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of Semtech (NASDAQ:SMTC) on 9/29/2026.
• Sold $15,001 – $50,000 in shares of ITT (NYSE:ITT) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Cytokinetics (NASDAQ:CYTK) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of YETI (NYSE:YETI) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of AtriCure (NASDAQ:ATRC) on 9/29/2026.

Revvity Stock Performance

Revvity stock traded down $0.92 during mid-day trading on Wednesday, reaching $154.16. 214,991 shares of the company’s stock were exchanged, compared to its average volume of 1,498,643. The business’s fifty day simple moving average is $134.17 and its 200 day simple moving average is $112.19. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. Revvity Inc. has a one year low of $81.22 and a one year high of $166.25. The firm has a market capitalization of $17.20 billion, a PE ratio of 73.61, a P/E/G ratio of 2.83 and a beta of 1.06.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. During the same period in the previous year, the firm earned $1.18 EPS. The firm’s quarterly revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, sell-side analysts expect that Revvity Inc. will post 5.36 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is 13.33%.

Insiders Place Their Bets

In other news, insider Tajinder Vohra sold 7,330 shares of the stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $140.88, for a total value of $1,032,650.40. Following the completion of the sale, the insider directly owned 6,635 shares of the company’s stock, valued at $934,738.80. This represents a 52.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Maxwell Krakowiak sold 1,631 shares of the firm’s stock in a transaction dated Monday, September 21st. The shares were sold at an average price of $144.53, for a total value of $235,728.43. Following the sale, the insider directly owned 14,781 shares in the company, valued at approximately $2,136,297.93. This represents a 9.94% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 9,130 shares of company stock valued at $1,290,745. Corporate insiders own 0.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on RVTY. Barclays boosted their price objective on Revvity from $115.00 to $160.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 7th. Weiss Ratings upgraded shares of Revvity from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. TD Cowen boosted their price objective on shares of Revvity from $130.00 to $175.00 and gave the company a “buy” rating in a research report on Tuesday. Sanford C. Bernstein assumed coverage on shares of Revvity in a research report on Friday, June 26th. They set a “market perform” rating and a $115.00 price target on the stock. Finally, Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Five equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $124.43.

Institutional Trading of Revvity

Institutional investors have recently bought and sold shares of the company. Ascentis Independent Advisors purchased a new stake in Revvity during the first quarter valued at $29,000. SJS Investment Consulting Inc. raised its holdings in Revvity by 5,210.0% in the 1st quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after purchasing an additional 521 shares during the period. Global Retirement Partners LLC bought a new stake in Revvity during the second quarter valued at about $51,000. Summit Securities Group LLC raised its stake in shares of Revvity by 294.6% in the first quarter. Summit Securities Group LLC now owns 663 shares of the company’s stock worth $58,000 after buying an additional 495 shares during the period. Finally, Contravisory Investment Management Inc. bought a new position in shares of Revvity during the 1st quarter valued at approximately $66,000. 86.65% of the stock is owned by hedge funds and other institutional investors.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Revvity

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.